Disease Registry Software Market Forecast: How Big Will It Be by 2030?

Uncover key drivers, emerging technologies, and competitive movements shaping the disease registry software market from 2026–2035 with trusted insights from The Business Research Company

How is the Disease Registry Software Market size predicted to change over the forecast window of 2026–2035?

The disease registry software market has seen significant expansion in recent years. It is projected to increase from $1.55 billion in 2025 to $1.73 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.4%. The historical growth of this market can be attributed to the escalating digitization of patient records, the proliferation of disease-specific research programs, rising regulatory reporting requirements, the widespread adoption of electronic health records, and the growing utilization of data-driven clinical decision tools.

The disease registry software market is anticipated to experience substantial growth in the coming years, with projections indicating it will expand to $2.64 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.1%. This expansion during the forecast period is primarily attributed to factors such as the escalating demand for population health analytics, increasing integration with AI-driven clinical insights, the broadened deployment of cloud-based registries, a heightened focus on outcomes-based healthcare, and the greater incorporation of real-world data in clinical research. Significant trends expected during this period include the rising adoption of integrated disease registry platforms, a surge in the utilization of cloud-based patient data management, an increased emphasis on regulatory-compliant data reporting, the proliferation of EHR-integrated registry solutions, and a stronger focus on gathering real-world evidence.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28208&type=smp

Which Drivers Are Contributing To The Expansion Of The Disease Registry Software Market?

The expanding integration of personalized medicine is projected to stimulate the growth of the disease registry software market in the coming years. Personalized medicine refers to a medical methodology that customizes treatment and prevention approaches tailored to an individual’s distinct genetic makeup, lifestyle, and environmental factors. The escalating acceptance of personalized medicine is predominantly driven by advancements in genomics, which facilitate precise identification of genetic variations and individualized treatment options. Disease registry software bolsters personalized medicine by systematically gathering and overseeing patient health data, thereby enabling tailored treatment regimens and more informed clinical choices. It also streamlines access to and analysis of data, consequently improving patient outcomes and furthering precision healthcare. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the disease registry software market.

What Segment Classifications Make Up The Disease Registry Software Market?

The disease registry software market covered in this report is segmented –

1) By Type: Standalone, Integrated

2) By Database: Public, Commercial

3) By Deployment Mode: On-Premises, Cloud-Based

4) By End-User: Hospitals, Government Organizations, Research Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Standalone: Patient Registry Software, Population Health Registry Software, Research Registry Software, Custom Or Single-Disease Registry Software

2) By Integrated: Electronic Health Record (EHR)-Integrated Registry Software, Practice Management System-Integrated Registry Software, Clinical Decision Support (CDS)-Integrated Registry Software, Health Information Exchange (HIE)-Integrated Registry Software

What Trends Are Projected To Support The Growth Of The Disease Registry Software Market?

Leading companies within the disease registry software market are concentrating on developing patient-centric registries, such as digital registers, to track outcomes and support individualized care. Digital registers denote electronic systems or software platforms engineered to systematically gather, store, and manage patient health information, replacing traditional paper-based registries. As an illustration, in August 2025, the American College of Cardiology (ACC), a US-based nonprofit medical association, introduced the CONNECT-HCM Registry. This nationwide digital registry was created to enhance the understanding and management of hypertrophic cardiomyopathy (HCM), which is the most common genetic cardiovascular disease. The registry facilitates direct patient enrollment beyond single centers, thereby closing long-standing diagnostic and care gaps. This platform connects registry data with electronic health records through Arboretum’s Hugo Connect platform, assisting researchers in monitoring symptoms, imaging, treatments, and outcomes over an extended period.

Which Major Firms Are Strengthening Their Position In The Disease Registry Software Market?

Major companies operating in the disease registry software market are Optum Inc., IQVIA Holdings Inc., Syneos Health Inc., Epic Systems Corporation, Premier Inc., MRO Corp., ImageTrend Inc., Anju Software Inc., BayaTree Inc., Medrio Inc., ArborMetrix Inc., Cedaron Medical Inc., Evado Pty. Ltd., OpenClinica LLC, Dacima Software Inc., Global Vision Technologies Inc., Ordinal Data Inc., Healthmonix LLC, Axis Clinical Software Inc., Vanderbilt University

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/disease-registry-software-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Disease Registry Software Market?

North America was the largest region in the disease registry software market in 2025. The regions covered in the disease registry software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Disease Registry Software Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28208&type=smp

Browse Through More Reports Similar to the Global Disease Registry Software Market 2026, By The Business Research Company

Healthcare Compliance Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-compliance-software-global-market-report

Disease Management Apps Market Report 2026

https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report

Personal Health Record Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795